Literature DB >> 14707088

T cytotoxic-1 CD8+ T cells are effector cells against pneumocystis in mice.

Florencia McAllister1, Florencia Mc Allister, Chad Steele, Mingquan Zheng, Erana Young, Judd E Shellito, Luis Marrero, Jay K Kolls.   

Abstract

Host defenses are profoundly compromised in HIV-infected hosts due to progressive depletion of CD4+ T lymphocytes. A hallmark of HIV infection is Pneumocystis carinii (PC) pneumonia. Recently, CD8+ T cells, which are recruited to the lung in large numbers in response to PC infection, have been associated with some level of host defense as well as contributing to lung injury in BALB/c mice. In this study, we show that CD8+ T cells that have a T cytotoxic-1 response to PC in BALB/c mice, as determined by secretion of IFN-gamma, have in vitro killing activity against PC and effect clearance of the organism in adoptive transfer studies. Moreover, non-T cytotoxic-1 CD8+ T cells lacked in vitro effector activity and contributed to lung injury upon adoptive transfer. This dichotomous response in CD8+ T cell response may in part explain the clinical heterogeneity in the severity of PC pneumonia.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14707088     DOI: 10.4049/jimmunol.172.2.1132

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  32 in total

1.  Streptococcus uberis-specific T cells are present in mammary gland secretions of cows and can be activated to kill S. uberis.

Authors:  Michel Denis; S Jane Lacy-Hulbert; Bryce M Buddle; John H Williamson; D Neil Wedlock
Journal:  Vet Res Commun       Date:  2011-02-01       Impact factor: 2.459

2.  Sensitized CD8+ T cells fail to control organism burden but accelerate the onset of lung injury during Pneumocystis carinii pneumonia.

Authors:  Francis Gigliotti; Elliott L Crow; Samir P Bhagwat; Terry W Wright
Journal:  Infect Immun       Date:  2006-08-28       Impact factor: 3.441

3.  Contribution of T cell subsets to the pathophysiology of Pneumocystis-related immunorestitution disease.

Authors:  Samir P Bhagwat; Francis Gigliotti; Haodong Xu; Terry W Wright
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2006-08-04       Impact factor: 5.464

4.  CD4+ T cell-independent DNA vaccination against opportunistic infections.

Authors:  Mingquan Zheng; Alistair J Ramsay; Myles B Robichaux; Corrine Kliment; Christopher Crowe; Rekha R Rapaka; Chad Steele; Florencia McAllister; Judd E Shellito; Luis Marrero; Paul Schwarzenberger; Qiu Zhong; Jay K Kolls
Journal:  J Clin Invest       Date:  2005-11-23       Impact factor: 14.808

Review 5.  Current understanding of Pneumocystis immunology.

Authors:  Michelle N Kelly; Judd E Shellito
Journal:  Future Microbiol       Date:  2010-01       Impact factor: 3.165

Review 6.  The immunology of parasite infections in immunocompromised hosts.

Authors:  T Evering; L M Weiss
Journal:  Parasite Immunol       Date:  2006-11       Impact factor: 2.280

7.  Regulatory T cells dampen pulmonary inflammation and lung injury in an animal model of pneumocystis pneumonia.

Authors:  Laura McKinley; Alison J Logar; Florencia McAllister; Mingquan Zheng; Chad Steele; Jay K Kolls
Journal:  J Immunol       Date:  2006-11-01       Impact factor: 5.422

8.  CD8+ cells enhance resistance to pulmonary serotype 3 Streptococcus pneumoniae infection in mice.

Authors:  Sarah E Weber; Haijun Tian; Liise-anne Pirofski
Journal:  J Immunol       Date:  2010-12-06       Impact factor: 5.422

9.  Pneumocystis jirovecii colonization is associated with enhanced Th1 inflammatory gene expression in lungs of humans with chronic obstructive pulmonary disease.

Authors:  Meghan E Fitzpatrick; John R Tedrow; Maria E Hillenbrand; Lorrie Lucht; Thomas Richards; Karen A Norris; Yingze Zhang; Frank C Sciurba; Naftali Kaminski; Alison Morris
Journal:  Microbiol Immunol       Date:  2014-03       Impact factor: 1.955

10.  Memory CD4+ T cells are required for optimal NK cell effector functions against the opportunistic fungal pathogen Pneumocystis murina.

Authors:  Michelle N Kelly; Mingquan Zheng; Sanbao Ruan; Jay Kolls; Alain D'Souza; Judd E Shellito
Journal:  J Immunol       Date:  2012-11-30       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.